300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Consumer
Energy
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Retail
Oil and Gas
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Legal
Software
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Climate
LGBT
Cannabis
Social
Celebrity
Life Science
Food and Beverage
Publishing
Infrastructure
Mobile Apps
Wine and Spirits
Beauty
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Fashion
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Zambia
Tajikistan
Oman
Romania
Puerto Rico
Poland
China
Cameroon
Guernsey
Colombia
Armenia
Costa Rica
Kenya
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Morocco
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uganda
Moldova
Uruguay
Seychelles
Botswana
South Africa
Paraguay
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Rwanda
Portugal
Sierra Leone
El Salvador
Tanzania
Senegal
India
Germany
United States
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Hungary
Belarus
Finland
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Lebanon
Cambodia
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Osaka Small and Medium Business investment & Consultation, VC Fund

Osaka Small and Medium Business investment & Consultation

VC Fund

Osaka, Japan

Osaka Small and Medium Business investment & Consultation is a public institution that supports the enhancement of equity capital.

Total investments:
3
Last investment:
Lead investor:
0%

Last updated:

Industries Osaka Small and Medium Business investment & Consultation invests in

Health CareBiotechnologyMedical DeviceMarket ResearchAlternative Medicine

Stages Osaka Small and Medium Business investment & Consultation invests in

SeedSeries AVenture - Series Unknown

Countries Osaka Small and Medium Business investment & Consultation invests in

Japan

Investment Focus

Industry

  • Health Care 2 (67%)
  • Biotechnology 1 (33%)
  • Medical Device 1 (33%)
  • Market Research 1 (33%)
  • Alternative Medicine 1 (33%)
See all 6 industries →

Stage

  • Seed 1 (33%)
  • Series A 1 (33%)
  • Venture - Series Unknown 1 (33%)

Investments

CompanyDescriptionRoundLinks
MiCAN Technologies MiCAN Technologies
MiCAN Technologies medical and nursing Care company we will provide the enabling tools to eliminate Malaria and other infectious diseases by the use of pluripotent stem cell. MiCAN Technologies through the provision of “blood cell-like cell products” produced using regenerative medicine technology,They will help you research malaria and otherinfectious and immune system diseases. $1.6M / Venture - Series Unknown / Jan 24, 2025
CellSeed CellSeed
CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment ofosteoarthritisThe company was founded in 2001 and is headquartered in Tokyo, Japan. $141.7M / Seed / Sep 30, 2005
Setsuro Tech Setsuro Tech
Seturotech is a biotechnology venture company established on February 22, 2017 by Tatsuya Takemoto (PI: Principal Investigator) of the University of Tokushima as a venture from Tokushima University. In 2015, Takemoto and Masakazu Hashimoto (Osaka University) developed a simple and highly efficient method for producing genetically modified(genome-edited) mice using CRISPR / Cas9, and filed a patent application for the technology. The technology is called fertilized egg electroporation (GEEP method), a technology that introduces molecules required for genome editing by CRISPR into fertilized eggs at high throughput by the power of electricity (electroporation). Using this technology, Seturotech will start from the production and sale of genetically modified mice, and will become a fundamental company providing all genetically modified animals, anticipating the future use of genetically modified animals in industry. $2.1M / Series A

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Consumer
Energy
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Retail
Oil and Gas
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Sports
Wellness
Biotechnology
Automotive
eSports
Legal
Software
Renewable Energy
Crowdfunding
Recruiting
Venture Capital
Web3
Medical
Theatre
Climate
LGBT
Cannabis
Social
Celebrity
Life Science
Food and Beverage
Publishing
Infrastructure
Mobile Apps
Wine and Spirits
Beauty
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Fashion
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Zambia
Tajikistan
Oman
Romania
Puerto Rico
Poland
China
Cameroon
Guernsey
Colombia
Armenia
Costa Rica
Kenya
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Mozambique
Namibia
Nicaragua
Mauritius
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Morocco
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uganda
Moldova
Uruguay
Seychelles
Botswana
South Africa
Paraguay
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Rwanda
Portugal
Sierra Leone
El Salvador
Tanzania
Senegal
India
Germany
United States
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Hungary
Belarus
Finland
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Lebanon
Cambodia
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Osaka Small and Medium Business investment & Consultation invest in?

Osaka Small and Medium Business investment & Consultation invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Osaka Small and Medium Business investment & Consultation last invest?

The most recent investment recorded for Osaka Small and Medium Business investment & Consultation closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Osaka Small and Medium Business investment & Consultation Osaka Small and Medium Business investment & Consultation Find emails